ISTHMUS PARTNERS, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
ISTHMUS PARTNERS, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$351,000
+17450.0%
9,328
+9228.0%
0.08%
+8400.0%
Q3 2018$2,000
+100.0%
1000.0%0.00%
Q2 2018$1,000
-50.0%
1000.0%0.00%
-100.0%
Q1 2018$2,0000.0%1000.0%0.00%0.0%
Q4 2017$2,0001000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders